Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation.
Liver failure caused by reactivation of hepatitis B virus (HBV) is an uncommon complication of bone marrow transplantation. Fibrosing cholestatic hepatitis is a recently described liver lesion that develops in some patients undergoing liver transplantation for chronic HBV infection. The lesion is characterised by peri portal fibrosis, ballooning degeneration of hepatocytes, prominent cholestasis and paucity of inflammation. Recent data suggests it is a cytopathic effect of the pre-core mutant form of HBV with over-expression of viral antigens. Although only one case has so far been described associated with bone marrow transplantation (BMT) it is likely that increasing use of BMT in people with chronic HBV infection will lead to further patients being recognised.
Cooksley
W G
WG
Clinical Research Centre, Royal Brisbane Hospital Foundation Bancroft Centre, Queensland, Australia.
McIvor
C A
CA
D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002780:Cholestasis, Intrahepatic / Q000175:diagnosis / Q000209:etiology*; D006509:Hepatitis B / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host